Latest current cash for THRD: $270M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Third Harmonic Bio posts a current cash of $270M as of March 2025. That compares with $260M in the prior-year period — up 3.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Third Harmonic Bio's current cash was $260M. The latest reading is $270M — a 3.3% year-over-year increase (period ending March 2025). Use the history and growth charts on this page for a longer lookback.
Current Cash is one piece of Third Harmonic Bio's financial statement story. At $270M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for THRD's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Third Harmonic Bio's other metric pages and overview cover the third.